Found: 5
Select item for more details and to access through your institution.
YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1069348
- By:
- Publication type:
- Article
Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2019, v. 12, p. 2597, doi. 10.2147/DMSO.S222323
- By:
- Publication type:
- Article
LncRNA ARAP1‐AS2 promotes high glucose‐induced human proximal tubular cell injury via persistent transactivation of the EGFR by interacting with ARAP1.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 22, p. 12994, doi. 10.1111/jcmm.15897
- By:
- Publication type:
- Article
HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 6, p. 1, doi. 10.1038/s41419-024-06780-w
- By:
- Publication type:
- Article
Genetically predicted body fat mass and distribution with diabetic kidney disease: A two-sample Mendelian randomization study.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.872962
- By:
- Publication type:
- Article